Fortress Biotech (FBIO) Net Cash Flow Growth (5y) (2015 - 2025)
Powered by 
Analysis
Fortress Biotech (FBIO) Net Cash Flow Growth (5y) (2015 - 2025) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.52 Bn | 133.66 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.69 Bn | 78.69 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.63 Bn | 59.45 Bn | 1.37 Bn |
| 4 | Moderna | 59.30 Bn | 54.16 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.41 Bn | 44.41 Bn | - |
| 6 | BeOne Medicines | 40.45 Bn | 35.35 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.29 Bn | 31.98 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - |
| 9 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn |
| 10 | Fortress Biotech | 86.15 Mn | -110.42 Mn | 12.58 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -19.70% |
| Sep 30, 2025 | -10.13% |
| Jun 30, 2025 | -18.72% |
| Mar 31, 2025 | 107.94% |
| Dec 31, 2024 | -23.48% |
| Sep 30, 2024 | -3.71% |
| Jun 30, 2024 | -17.40% |
| Mar 31, 2024 | -45.40% |
| Dec 31, 2023 | 23.17% |
| Sep 30, 2023 | -21.45% |
| Jun 30, 2023 | -22.79% |
| Mar 31, 2023 | -35.76% |
| Dec 31, 2022 | -38.79% |
| Sep 30, 2022 | -4.28% |
| Jun 30, 2022 | -41.91% |
| Mar 31, 2022 | -19.12% |
| Dec 31, 2021 | 51.67% |
| Sep 30, 2021 | -31.87% |
| Jun 30, 2021 | -8.14% |
| Mar 31, 2021 | 39.97% |